Questions

57. Deputy Seán Crowe asked the Tánaiste and Minister for Finance his views on the distinction in the VAT rate between oral and injectable medications; if there are plans to include injectable medicines under annex III of the EU VAT Directive in order that the VAT rate can be equalised at 0%; and if he will make a statement on the matter. [40430/26]

1939. Deputy Seán Crowe asked the Minister for Health if a pricing and reimbursement application has been received by the HSE for zolbetuximab (Vyloy®); if the national assessment and decision process has begun; and if she will make a statement on the matter. [19668/26]

118. Deputy Seán Crowe asked the Minister for Health for an update on the approval status of the drug givinostat; if officials from her Department have been in contact with their counterparts in the North of Ireland to examine the possibility of children with Duchenne muscular dystrophy accessing treatment in the North as an interim measure; if not, to outline the barriers to them doing so; and if she will make a sta…

1277. Deputy Seán Crowe asked the Minister for Health the reason that a medication (details supplied) for the treatment of diabetes insipidus has been removed from the long-term illness scheme; and her views on whether beneficiaries of the scheme should be informed of changes to approved medication rather than discovering this when renewing prescriptions. [48600/25]

207. Deputy Seán Crowe asked the Minister for Health if the drug vamorolone is currently being considered for approved use by the HSE. [6471/25]

222. Deputy Seán Crowe asked the Minister for Health if the drug givinostat is being considered for approval for use by the HSE. [6585/25]